Fangfang Jin

Key Laboratory Of Laboratory Medical Diagnostics Designated By The Ministry Of Education
Chongqing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Engineered red blood cell extracellular vesicles for delivery of Dox and siIDO1 enhance targeted chemo-immunotherapy of acute myeloid leukemia.

Engineered red blood cell extracellular vesicles for delivery of Dox and siIDO1 enhance targeted chemo-immunotherapy of acute myeloid leukemia.

Journal: Journal for immunotherapy of cancer
Published: June 28, 2025

NRF2 maintains redox balance via ME1 and NRF2 inhibitor synergizes with venetoclax in NPM1-mutated acute myeloid leukemia.

NRF2 maintains redox balance via ME1 and NRF2 inhibitor synergizes with venetoclax in NPM1-mutated acute myeloid leukemia.

Journal: Cancer & metabolism
Published: January 29, 2025

Engineered cell membrane vesicles loaded with lysosomophilic drug for acute myeloid leukemia therapy via organ-cell-organelle cascade-targeting.

Engineered cell membrane vesicles loaded with lysosomophilic drug for acute myeloid leukemia therapy via organ-cell-organelle cascade-targeting.

Journal: Biomaterials
Published: July 23, 2024

Dual-aptamer-engineered M1 macrophage with enhanced specific targeting and checkpoint blocking for solid-tumor immunotherapy.

Dual-aptamer-engineered M1 macrophage with enhanced specific targeting and checkpoint blocking for solid-tumor immunotherapy.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: June 21, 2024

Cytoplasmic TP53INP2 acts as an apoptosis partner in TRAIL treatment: the synergistic effect of TRAIL with venetoclax in TP53INP2-positive acute myeloid leukemia.

Cytoplasmic TP53INP2 acts as an apoptosis partner in TRAIL treatment: the synergistic effect of TRAIL with venetoclax in TP53INP2-positive acute myeloid leukemia.

Journal: Journal of experimental & clinical cancer research : CR
Published: March 30, 2024

PDK1 promotes breast cancer progression by enhancing the stability and transcriptional activity of HIF-1α.

PDK1 promotes breast cancer progression by enhancing the stability and transcriptional activity of HIF-1α.

Journal: Genes & diseases
Published: March 02, 2023

Correction to: Progranulin induces immune escape in breast cancer via up-regulating PD-L1 expression on tumor-associated macrophages (TAMs) and promoting CD8+ T cell exclusion.

Correction to: Progranulin induces immune escape in breast cancer via up-regulating PD-L1 expression on tumor-associated macrophages (TAMs) and promoting CD8+ T cell exclusion.

Journal: Journal of experimental & clinical cancer research : CR
Published: March 13, 2022

Dual-aptamer-engineered M1 macrophage with enhanced specific targeting and checkpoint blocking for solid-tumor immunotherapy.

Dual-aptamer-engineered M1 macrophage with enhanced specific targeting and checkpoint blocking for solid-tumor immunotherapy.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 21, 2022

Dual-Targeted Self-Assembled DNA Hydrogels Decorated With Multivalent Aptamers Loaded With DOX for Anticancer Therapy.

Dual-Targeted Self-Assembled DNA Hydrogels Decorated With Multivalent Aptamers Loaded With DOX for Anticancer Therapy.

Journal: Frontiers in pharmacology
Published: November 11, 2021

The miR-345-3p/PPP2CA signaling axis promotes proliferation and invasion of breast cancer cells.

The miR-345-3p/PPP2CA signaling axis promotes proliferation and invasion of breast cancer cells.

Journal: Carcinogenesis
Published: October 14, 2021

Progranulin induces immune escape in breast cancer via up-regulating PD-L1 expression on tumor-associated macrophages (TAMs) and promoting CD8+ T cell exclusion.

Progranulin induces immune escape in breast cancer via up-regulating PD-L1 expression on tumor-associated macrophages (TAMs) and promoting CD8+ T cell exclusion.

Journal: Journal of experimental & clinical cancer research : CR
Published: September 16, 2020
Showing 1-11 of 11

Last Updated: 09/26/2026